Pancreatic cancer is usually detected at late stages and most patients die within one year after diagnosis.
In PANCAID we will therefore develop a blood test for early detection of pancreatic cancer. Despite tremendous technological advances in Liquid Biopsy Diagnostics (LBx), this goal is very ambitious because small tumors release only minute amounts of cells or cellular products (e.g., DNA, RNA, protein, metabolites) into the circulation. Thus, tests with a high sensitivity are required but increases in sensitivity are usually achieved on the expenses of reduced specificity which can lead to significant overdiagnosis leading to unnecessary stress for the individuals with a false-positive blood test and high costs for the health system.
In PANCAID, we will therefore establish a blood test with high accuracy by analyzing large cohorts of patients with PDAC and its precursor lesions, individuals at risk to develop pancreatic cancer and appropriate age-matched control groups.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.
Company Details
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://www.pancaid-project.eu
- Competitors
- PCE Pancreatic Cancer Europe, PANCAIM, IHI READI, concentris research management GmbH, GUIDE.MRD, OncoDaily, Cancer Prevention and Early Detection (Screening), Liquid Biopsy LCCRH Lab - Laboratoire Cellules Circulantes Rares Humaines, DIOPTRA Project, International Symposium on Minimal Residual Cancer.
Pancaid Questions
Pancaid's website is https://www.pancaid-project.eu
Pancaid's LinkedIn profile is https://www.linkedin.com/company/pancaid
Pancaid's industry is
Research Services
Pancaid's top competitors are
Pce Pancreatic Cancer Europe,
Pancaim,
Ihi Readi,
Concentris Research Management Gmbh,
Guide.mrd,
Oncodaily,
Cancer Prevention And Early Detection (Screening),
Liquid Biopsy Lccrh Lab - Laboratoire Cellules Circulantes Rares Humaines,
Dioptra Project,
International Symposium On Minimal Residual Cancer.
Pancaid's categories are Research Services
